World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

World Health Organization : Year 1990, World Health Organization, Programme on Substance Abuse, No. 90.5: Information Manual on Designer Drugs

By Hans Emblad

Click here to view

Book Id: WPLBN0000081137
Format Type: PDF eBook
File Size: 2.8 MB
Reproduction Date: 2005
Full Text

Title: World Health Organization : Year 1990, World Health Organization, Programme on Substance Abuse, No. 90.5: Information Manual on Designer Drugs  
Author: Hans Emblad
Volume:
Language: English
Subject: Health., Public health, Wellness programs
Collections: Medical Library Collection, World Health Collection
Historic
Publication Date:
Publisher: World Health Organization

Citation

APA MLA Chicago

Emblad, H. (n.d.). World Health Organization : Year 1990, World Health Organization, Programme on Substance Abuse, No. 90.5. Retrieved from http://hawaiilibrary.net/


Description
Medical Reference Publication

Excerpt
Psychoactive drugs have been part of human life since ancient times. First, drugs of natural origin or vegetable drugs such as opium, cannabis and coca leaves ware used. During the first half of the 20th century classical synthetic drugs such as pethidine, methadone, LSD, amfetamrnes and depressants were added. Most of these drugs were placed under international control under either the Single Convention on Narcotic Drugs of 1961 or the Convention on Psychotropic Substances of 1971. Since the late 1970s, new types of synthetic drugs have emerged. They are similar to controlled substances in chemical structure and pharmacological activity, but different enough to avoid legal control applicable to the mother compounds. These analogues of controlled substances are often referred to as designer drugs, because they are designed by chemists in clandestine laboratories in an attempt to circumvent drug control laws.

Table of Contents
CONTENTS Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fantanyl Analogues ........................................... General History .................................................. Pharmacology ..................................................... Toxicology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clinical Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clandestine Synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Analytical Chemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Data Sheets Fentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Alpha-rnethylfentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AcetyT-alpha-methylfentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Alpha-methylthiofentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-Methylfentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Para-fluorofsntanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beta-hydroxyfentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Beta-hydroxy-3-methylfentanyl .............................. Thiofentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3-Methylthiofentanyl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . MeperFdXne Analogues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . General History . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pharmacology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Toxicology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clinical Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clandestine Synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Analytical Chemistry ............................................. Data Sheets Meperidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . l-Methyl-4-phenyl-4-propionoxypiperidine. . . . . . . . . . . . . . . . . . . l.Methyl.4.phenyl-1.2.3.6.tetrahydropyridine . . . . . . . . . . . . . . . 1-(2-Phenethyl)-4-pheny1-4-acetyloxyplperidine . . . . . . . . . . . . . 1-(3-Dxo-3-phenylpropyl)-4-phenyl-l-propylpiperid~e . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amfetamine Analogues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . General History . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Pharmacology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Toxicology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clinical Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clandestine Synthesis ............................................ Analytical Chemistry ............................................. Data Sheets 3,4 ~Methylenedioxyamfet

 

Click To View

Additional Books


  • Bulletin of the World Health Organizatio... (by )
  • World Health Organization : Press Releas... (by )
  • World Health Organization : Year 2005 ; ... (by )
  • World Health Organization : Year 1992, A... (by )
  • World Health Organization : World Health... (by )
  • World Health Organization : Regional Off... (by )
  • World Health Organization : Year 1988 ; ... (by )
  • World Health Organization, Weekly Epidem... (by )
  • World Health Organization, Weekly Epidem... (by )
  • World Health Organization, Weekly Epidem... (by )
  • World Health Organization, Weekly Epidem... (by )
  • Regional Office for Africa : 1994-99 ; C... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from Hawaii eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.